Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

61. Dosage Delivery of ADHD Medications for Patients with Swallowing Difficulties: Guidelines

Dosage Delivery of ADHD Medications for Patients with Swallowing Difficulties: Guidelines Dosage Delivery of ADHD Medications for Patients with Swallowing Difficulties: Guidelines | CADTH.ca Find the information you need Dosage Delivery of ADHD Medications for Patients with Swallowing Difficulties: Guidelines Dosage Delivery of ADHD Medications for Patients with Swallowing Difficulties: Guidelines Published on: September 3, 2015 Project Number: RB0905-000 Product Line: Research Type: Drug (...) Report Type: Summary of Abstracts Result type: Report Question What is the clinical evidence regarding methods of dosage delivery of attention deficit hyperactivity disorder (ADHD) medications to patients with swallowing difficulties? What are the evidence-based guidelines regarding method of dosage delivery of ADHD medications to patients with swallowing difficulties? Key Message One evidence-based guideline was identified regarding methods of dosage delivery of ADHD medications to patients

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

62. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research

Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD)delivered in school settings: systematic reviews of quantitative and qualitative research Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page

Full Text available with Trip Pro

2015 NIHR HTA programme

63. Medical augmentation of labor and the risk of ADHD in offspring: a population-based study (PubMed)

Medical augmentation of labor and the risk of ADHD in offspring: a population-based study Oxytocin for labor augmentation is widely used in obstetric care in Western countries. Two recent, smaller studies found opposing results regarding the association between prenatal exposure to oxytocin for labor augmentation and attention-deficit/hyperactivity disorder (ADHD). In Denmark, oxytocin is the medication used for nearly all medical augmentations of labor, and we examined the association between (...) medical augmentation of labor and ADHD in a large cohort study based on national register data.All singletons born after spontaneous onset of labor in Denmark between 2000 and 2008 (N = 546 146) were included in the study. Data from the Danish Medical Birth Registry on medical augmentation of labor (yes/no) were used to identify exposed children. ADHD was defined based on the diagnostic codes of International Classification of Diseases, 10th Revision, for hyperkinetic disorder and information

Full Text available with Trip Pro

2015 EvidenceUpdates

64. Miscellaneous: Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation

Miscellaneous: Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Telepsychiatry intervention is better for ADHD symptoms than usual treatment augmented by telemedicine consultation Article Text Electronic

2015 Evidence-Based Mental Health

65. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. (PubMed)

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Symptoms of attention deficit hyperactivity disorder (ADHD), diagnosed mainly in children, often persist into adulthood. Adults in this group have a high rate of other psychiatric problems and functional difficulties in a number of key areas such as academic achievement, interpersonal relationships, and employment. Although the usefulness of immediate-release methylphenidate in children has been (...) authors of recently published trials.We included all randomized trials comparing immediate-release methylphenidate versus placebo in participants aged 18 years or older with ADHD. We excluded trials conducted on subpopulations of adults with ADHD such as adults with both ADHD and substance dependence.Two review authors independently selected trials, extracted data, and assessed trial risk of bias. We contacted authors of trials to ask for additional and missing data. For dichotomous outcomes, we

2014 Cochrane

66. ADHD: medication and society

ADHD: medication and society ADHD: medication and society ADHD: medication and society Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. ADHD: medication and society. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2014/19. 2014 Final publication URL Indexing Status Subject

2014 Health Technology Assessment (HTA) Database.

67. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments

Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments Sonuga-Barke EJ, Brandeis D, Cortese S, Daley (...) D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Dopfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J, European ADHD Guidelines Group CRD summary Free fatty acid supplementation and artificial food colour exclusions appeared to have benefits for attention deficit hyperactivity disorder (ADHD); the evidence for behavioural interventions was limited. The authors’ conclusions seem reliable

2014 DARE.

68. Management of ADHD in preschool-aged children

Management of ADHD in preschool-aged children Management of ADHD in preschool-aged children Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Management of ADHD in preschool-aged children View/ Open Date 2013-09 Format Metadata Abstract Behavior therapy interventions, such as parent training, are first-line treatment (...) for ADHD in preschool-aged children (three to five years of age). (Strength of Recommendation [SOR]: B, based on a systematic review of a small number of heterogeneous randomized controlled trials [RCTs].) Medication is an option for children with moderate to severe ADHD if behavior therapy has not been effective and if the benefits outweigh the harms. (SOR: B, based on a systematic review of a small number of heterogeneous RCTs.) Alternative therapies, such as elimination diets, have limited evidence

2014 Clinical Inquiries

69. Atomoxetine (Strattera) - adults with attention deficit hyperactivity disorder (ADHD)

Atomoxetine (Strattera) - adults with attention deficit hyperactivity disorder (ADHD) All Wales Medicines Strategy Group (AWMSG) - atomoxetine (Strattera) | | Appraisal information Search and reports atomoxetine (Strattera®) Reference No. 1361 Publication date: 27/02/2014 Last review date: 01/12/2016 Appraisal information atomoxetine (Strattera®) 10 mg capsule atomoxetine (Strattera®) 18 mg capsule atomoxetine (Strattera®) 25 mg capsule atomoxetine (Strattera®) 40 mg capsule atomoxetine (...) NHS Wales for the initiation of treatment in adults with attention deficit hyperactivity disorder (ADHD). Treatment must be initiated by a specialist in the treatment of ADHD, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria or the guidelines in International Classification of Mental and Behavioural Disorders (ICD). In adults, the presence of symptoms of ADHD

2014 All Wales Medicines Strategy Group

70. Autism traits may be more prevalent in ADHD than previously reported

Autism traits may be more prevalent in ADHD than previously reported Autism traits may be more prevalent in ADHD than previously reported | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password (...) * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Autism traits may be more prevalent in ADHD than previously reported Article Text Prevalence, assessment and diagnosis Autism traits may be more prevalent in ADHD than previously reported Kevin Antshel Statistics from Altmetric.com What is already known

2014 Evidence-Based Mental Health

71. Atomoxetine is a second-line medication treatment option for ADHD

Atomoxetine is a second-line medication treatment option for ADHD Atomoxetine is a second-line medication treatment option for ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password (...) * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Atomoxetine is a second-line medication treatment option for ADHD Article Text Pharmacological interventions Atomoxetine is a second-line medication treatment option for ADHD Jaswinder K Ghuman 1 , Shari L Hutchison 2 Statistics from Altmetric.com What

2014 Evidence-Based Mental Health

72. Medication reduces crash risk among men with ADHD

Medication reduces crash risk among men with ADHD Medication reduces crash risk among men with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Medication reduces crash risk among men with ADHD Article Text Causes and risk factors Medication reduces crash risk among men with ADHD Flaura Koplin Winston 1 , Daniel Romer 2 Statistics from Altmetric.com What is already known on this topic? Safe driving requires ‘situation awareness’, a combined

2014 Evidence-Based Mental Health

73. Review: recommendations for the assessment and management of sleep disorders in ADHD

Review: recommendations for the assessment and management of sleep disorders in ADHD Review: recommendations for the assessment and management of sleep disorders in ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: recommendations for the assessment and management of sleep disorders in ADHD Article Text Outcomes Review: recommendations for the assessment and management of sleep disorders in ADHD Statistics from

2014 Evidence-Based Mental Health

74. Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence

Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence Article Text Causes Review: no evidence that stimulant

2014 Evidence-Based Mental Health

75. Systematic review with meta-analysis: Stimulant medication for ADHD not associated with subsequent substance use disorders

Systematic review with meta-analysis: Stimulant medication for ADHD not associated with subsequent substance use disorders Stimulant medication for ADHD not associated with subsequent substance use disorders | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Stimulant medication for ADHD not associated with subsequent substance use disorders Article Text Aetiology Systematic review with meta-analysis Stimulant medication for ADHD

2014 Evidence-Based Medicine (Requires free registration)

76. Lisdexamfetamine dimesylate (Elvanse) - attention deficit/hyperactivity disorder (ADHD)

Lisdexamfetamine dimesylate (Elvanse) - attention deficit/hyperactivity disorder (ADHD) All Wales Medicines Strategy Group (AWMSG) - lisdexamfetamine dimesylate (Elvanse) | | Appraisal information Search and reports lisdexamfetamine dimesylate (Elvanse®) Reference No. 188 Publication date: 03/12/2013 Last review date: 01/12/2016 Appraisal information lisdexamfetamine dimesylate (Elvanse®) 30 mg capsule lisdexamfetamine dimesylate (Elvanse®) 50 mg capsule lisdexamfetamine dimesylate (Elvanse® (...) programme for attention deficit/hyperactivity disorder (ADHD) in children aged six years of age and over when response to previous methylphenidate treatment is considered clinically inadequate. Treatment must be under the supervision of a specialist in childhood and/or adolescent behavioural disorders. Final Appraisal Recommendation (FAR) Download AWMSG Secretariat Appraisal Report (ASAR) Download Clinical Expert (CE) Summary Download |

2013 All Wales Medicines Strategy Group

77. Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy

Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy Punja S, Zorzela L, Hartling L, Urichuk L, Vohra S CRD summary This review concluded that long-acting (...) the core symptoms of paediatric attention deficit hyperactivity disorder (ADHD). Searching MEDLINE, Pre-MEDLINE, CINAHL, EMBASE, PsycINFO and Cochrane Central Register of Controlled Trials (CENTRAL) were searched for studies published in English, from 1950 to August 2012. Search terms were reported. Reference lists of included studies were scanned to identify more studies. Study selection Randomised controlled trials (RCTs) that compared long-acting methylphenidate with short-acting methylphenidate

Full Text available with Trip Pro

2013 DARE.

78. Interventions for Preschool Children at High Risk for ADHD: A Comparative Effectiveness Review (PubMed)

Interventions for Preschool Children at High Risk for ADHD: A Comparative Effectiveness Review The US Agency for Healthcare Research and Quality sponsored a comparative effectiveness review of interventions for preschoolers at risk for attention-deficit/hyperactivity disorder (ADHD).Medline, Cochrane CENTRAL, Embase, PsycInfo, and Education Resources Information Center were searched from 1980 to November 24, 2011. Selected studies were comparative, and enrolled children <6 years with clinically (...) significant disruptive behavior, including ADHD. The interventions evaluated were parent behavior training (PBT), combined home and school/day care interventions, and methylphenidate use. Data were extracted by using customized software. Two independent raters evaluated studies as good, fair, or poor by using the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies Risk of Bias. Overall strength of evidence (SOE) was rated for each intervention's effectiveness

Full Text available with Trip Pro

2013 EvidenceUpdates

79. Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments (PubMed)

Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments Nonpharmacological treatments are available for attention deficit hyperactivity disorder (ADHD), although their efficacy remains uncertain. The authors undertook meta-analyses of the efficacy of dietary (restricted elimination diets, artificial food color exclusions, and free fatty acid supplementation) and psychological (cognitive training (...) , neurofeedback, and behavioral interventions) ADHD treatments.Using a common systematic search and a rigorous coding and data extraction strategy across domains, the authors searched electronic databases to identify published randomized controlled trials that involved individuals who were diagnosed with ADHD (or who met a validated cutoff on a recognized rating scale) and that included an ADHD outcome.Fifty-four of the 2,904 nonduplicate screened records were included in the analyses. Two different analyses

2013 EvidenceUpdates

80. Review: little evidence that PUFA supplementation improves symptoms in ADHD

Review: little evidence that PUFA supplementation improves symptoms in ADHD Review: little evidence that PUFA supplementation improves symptoms in ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: little evidence that PUFA supplementation improves symptoms in ADHD Article Text Therapeutics Review: little evidence that PUFA supplementation improves symptoms in ADHD Statistics from Altmetric.com Question Question: How

2013 Evidence-Based Mental Health